Current issues in Hereditary Angioedema (HAE) - Ipopi
Current issues in Hereditary Angioedema (HAE) - Ipopi
Current issues in Hereditary Angioedema (HAE) - Ipopi
SHOW LESS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Treatment of C1 <strong>in</strong>hibitor deficiency<br />
-icatibant (Firazyr)<br />
Mean VAS scores vs. time for the primary symptom<br />
Mean VAS [mm]<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Icatibant (JE049 #2102)<br />
Tranexamic acid<br />
Icatibant (JE049 #2103)<br />
Placebo<br />
0 1 2 3 4 5 6 7 8 9 10 11 12<br />
Time po<strong>in</strong>t [h]
Change language